MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 94 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $351,000 | -70.4% | 283,445 | -26.2% | 0.00% | – |
| Q1 2017 | $1,184,000 | -69.0% | 384,089 | -58.9% | 0.00% | -100.0% |
| Q4 2016 | $3,815,000 | +42.4% | 935,017 | +121.6% | 0.00% | +100.0% |
| Q3 2016 | $2,679,000 | +830.2% | 421,969 | +690.2% | 0.00% | – |
| Q2 2016 | $288,000 | -73.5% | 53,400 | -58.9% | 0.00% | – |
| Q1 2016 | $1,087,000 | +36.7% | 129,869 | +29.1% | 0.00% | – |
| Q4 2015 | $795,000 | -68.3% | 100,578 | -65.9% | 0.00% | – |
| Q3 2015 | $2,506,000 | -49.6% | 294,555 | -26.7% | 0.00% | -100.0% |
| Q2 2015 | $4,971,000 | +37.9% | 402,023 | +32.4% | 0.00% | +100.0% |
| Q1 2015 | $3,606,000 | -27.4% | 303,580 | -30.9% | 0.00% | -50.0% |
| Q4 2014 | $4,965,000 | -6.7% | 439,379 | -27.5% | 0.00% | 0.0% |
| Q3 2014 | $5,321,000 | -12.3% | 606,002 | -27.2% | 0.00% | -33.3% |
| Q2 2014 | $6,068,000 | +99.0% | 832,367 | +37.6% | 0.00% | +200.0% |
| Q1 2014 | $3,050,000 | -50.7% | 605,127 | -47.8% | 0.00% | -66.7% |
| Q4 2013 | $6,190,000 | +864.2% | 1,159,240 | +586.5% | 0.00% | – |
| Q3 2013 | $642,000 | +65.5% | 168,868 | +193.2% | 0.00% | – |
| Q2 2013 | $388,000 | – | 57,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |